Page last updated: 2024-10-27

fentanyl and Daytime Sleepiness

fentanyl has been researched along with Daytime Sleepiness in 2 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Research Excerpts

ExcerptRelevanceReference
"The fentanyl transdermal matrix patch is approved in Japan for the management of moderate to severe cancer-related pain in adults."7.74Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain. ( Hoy, SM; Keating, GM, 2008)
"The fentanyl transdermal matrix patch is approved in Japan for the management of moderate to severe cancer-related pain in adults."3.74Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain. ( Hoy, SM; Keating, GM, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoy, SM1
Keating, GM1
Seccareccia, D1

Reviews

1 review available for fentanyl and Daytime Sleepiness

ArticleYear
Pain patch.
    Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:9

    Topics: Abdominal Pain; Administration, Cutaneous; Aged; Analgesics, Opioid; Confusion; Disorders of Excessi

2007

Other Studies

1 other study available for fentanyl and Daytime Sleepiness

ArticleYear
Fentanyl transdermal matrix patch (Durotep MT patch; Durogesic DTrans; Durogesic SMAT): in adults with cancer-related pain.
    Drugs, 2008, Volume: 68, Issue:12

    Topics: Administration, Cutaneous; Adult; Analgesics, Opioid; Area Under Curve; Clinical Trials, Phase II as

2008